CIMA Labs Licenses Fast-Dissolving Fentanyl to Taiho
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 43 (Table of Contents)
Published: 4 Jan-2004
DOI: 10.3833/pdr.v2004.i43.839 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
CIMA Labs licensed the exclusive rights to its fast-dissolving OraVescent® (fentanyl) formulation of the breakthrough cancer pain treatment to Taiho Pharmaceutical...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS